ClinicalTrials.Veeva

Menu

Tobacco Exposure and Influencing Factors of Smoking Cessation Among Chronic Kidney Disease Patients

Sun Yat-sen University logo

Sun Yat-sen University

Status

Completed

Conditions

Smoking Cessation

Treatments

Other: Questionnaires set

Study type

Observational

Funder types

Other

Identifiers

NCT06303089
zzwee-quit (CKD) 23152

Details and patient eligibility

About

The purpose of this study is to describe the tobacco exposure and characteristics of patients with Chronic Kidney Disease (CKD) who quit smoking, to identify patients' tobacco-related knowledge, attitude, and practice (KAP) and explore the influencing factors of smoking cessation.

Full description

Participants will be invited to recall their smoking status and tobacco-related KAP. Smokers need to identify their smoking cessation behavior.

First part: participants need to finish the questionnaire, which includes the demographic information sheet, characteristics of smoking sheet, and tobacco-related KAP. Including (a) patients' knowledge of health risks of tobacco and tobacco-related diseases (the delphi method was used to construct this knowledge questionnaire); and (b) perceptions of tobacco harm.

Second part: smokers need to finish the questionnaire, which includes history of smoking cessation sheet, attitudes towards tobacco control smoking cessation, nicotine dependence sheet, tobacco withdrawal symptoms sheet, intention to quit smoking sheet, ability to quit smoking sheet, alcohol use disorders and physical activity.

Enrollment

567 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Participants aged 18 years or older;
  2. Participants with a confirmed diagnosis of Chronic Kidney Disease;
  3. Participants were able to speak and read Chinese.;

Exclusion criteria

  1. Participants who with psychiatric illness, disorders of consciousness, communication impairments, were unable to communicate effectively;
  2. Participants who have acute and life-threatening exacerbations which require urgent treatment;
  3. Patients who currently involved in other smoking cessation programs.

Trial design

567 participants in 1 patient group

Questionnaires assessed Chronic Kidney Disease patients
Description:
Participants who met the inclusion criteria below will be invited to fill in tobacco exposure questionnaires, smokers will be invited to complete smoking cessation questionnaires set. 1. Participants aged 18 years or older; 2. Participants with a confirmed diagnosis of Chronic Kidney Disease;
Treatment:
Other: Questionnaires set

Trial contacts and locations

1

Loading...

Central trial contact

Zhu Wei, BA; Wei Xia, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems